Skip to content

Clinical trials

Phase 2 Hemorrhage trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Phase: Phase 2 Country / region: France Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20111
20132
20181
20192
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sangart3
Centre Hospitalier Universitaire de Saint Etienne2
Assistance Publique - Hôpitaux de Paris1
Centre Chirurgical Marie Lannelongue1
Novartis Pharmaceuticals1
University Hospital, Clermont-Ferrand1
University Hospital, Toulouse1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage10
Acidosis, Lactic3
Shock, Hemorrhagic3
Wounds and Injuries3
Shock, Traumatic2
Thrombocytopenia2
Thrombosis2
Colitis1
Diarrhea1
Hematologic Neoplasms1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.